Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112210512 | 11221051 | 2 | F | 2011 | 20160801 | 20150626 | 20160812 | PER | US-BAYER-2015-347409 | BAYER | 0.00 | E | F | Y | 65.76000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112210512 | 11221051 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, UNK | 21085 | 400 | MG | FILM-COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112210512 | 11221051 | 1 | Influenza |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112210512 | 11221051 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112210512 | 11221051 | Altered visual depth perception | |
112210512 | 11221051 | Emotional distress | |
112210512 | 11221051 | Gait disturbance | |
112210512 | 11221051 | Injury | |
112210512 | 11221051 | Muscle spasms | |
112210512 | 11221051 | Neuropathy peripheral | |
112210512 | 11221051 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112210512 | 11221051 | 1 | 20111130 | 20111209 | 0 |